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Purpose/Objective: To present and analyze clinical results 
obtained with an in house two-dimensional EPID-based in vivo 
dose reconstruction algorithm on head and neck cancers 
treated by intensity-modulated radiation therapy (IMRT). 
Materials and Methods: Our modela enables two dimensional 
dose distributions inside a patient to be reconstructed from 
portal images. Doses are backprojected inside patients in the 
isocenter plan perpendicular to the beam axis. The algorithm 
was developed in Matlab™ V.R2012b and was created for an 
aS-500/2 irradiated by a 6 MV photon beam energy on a 
Clinac iX (Varian Medical System™, Palo Alto, CA, USA). 
3 head & neck IMRT treatment plan were used in this work 
which represents 18 different dose reconstructions. For each 
field, the dose calculated from EPID signal was compared to 
the dose calculated with our treatment planning system 
(Eclipse™ v.10) using the γ-evaluation method with 5% or 3% 
of the maximum dose delivered as dose difference criterion 
and 3 mm as distance-to-agreement criterion.  
Results: The average of points satisfying the γ-criteria is 
equal to 96.1 % ± 1.7 % with a 5% dose difference criterion 
and 92.5 % ± 1.9 % with a 3% dose difference criterion for the 
18 fields studied. The analysis of gamma distribution showed 
good agreement between reconstructed and calculated 
doses. Major differences were observed for pixels located in 
front of heterogeneities (air / bones / prosthesis). 
Conclusions: Results obtained here confirm that the 
developed algorithm is usable in clinical routine to perform 
in vivo dosimetry on head and neck cancers treated by IMRT. 
In the future, heterogeneity correction should be developed 
in order to obtain a powerful IMRT quality assurance tool. 
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Purpose/Objective: The objective of the R&D project is to 
develop an innovative mobile electron accelerator for IOERT. 
This report describes the progress of the project, its current 
status and future plans. 
Materials and Methods: The work was divided into two major 
milestones. The first objective was to develop a machine 
which key functionalities are an electron beam with energy 
from 4 to 12 MeV and a robotic manipulator with significant 
range of movement. A demonstrator machine was built from 
scratch at National Centre for Nuclear Research (NCBJ). The 
scope of work of this project phase (2008-2014) included 
beam dynamics modeling, Monte Carlo modeling, mechanical 
construction and electrical schemes, as well as development 
of a control system.  
The second project phase started at the beginning of 2014, 
and aimed at preparing a functional prototype of the 
complex system that emphasizes optimal ease of use in 
clinical environment. This phase is being carried out by a 
consortium of NCBJ, the Greater Poland Cancer Centre 
(clinical experts in IOERT) and two private companies that 
will be responsible for production of the new IOERT machine. 
Results: Beam characteristics: Most probable energy on 
phantom surface Ep0 – 12,21 MeV with depth of 90% isodose – 
33,70 mm; symmetry for each energy (4, 6, 9, 12 MeV) and 
each applicator size (3, 5, 10, 12 cm) - less than 102%. 
Mechanical parameters: the demonstrator device consists of 
an accelerator that is mounted on a robotic manipulator with 
six degrees of freedom. The manipulator consists of a trolley, 
pillar, crane and treatment head (Fig. 1). The trolley can 
move forward and backward, and turn left and right, the 
pillar can rotate the whole accelerator ± 90°. The crane 
holds the treatment head at its front end and microwave 
components at its rear. Crane tilt ranges from +30° to -20° 
with rotation range of ±45° and applies to the head mounted 
on the crane. The treatment head holds the accelerating 
structure and beam forming system and has a tilt range of 
±60°. 
 
 
Fig. 1: Device overview 
